News

Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Older Americans worried about cognitive decline can stay sharper for longer by exercising both their bodies and their brains ...
The therapies, which are just starting to enter clinical trials, will need to prove clear clinical and quality-of-life ...
The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for ...
Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.
As the popularity of the type-2 diabetes drugs have risen, researcher have been looking into different aspects of it to ensure safety. One such research has shown that it could help prevent cognitive ...
GLP-1 drugs may reduce asthma symptoms in obese adults, offering a steroid-free alternative to treatment. The study includes ...